Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm, Residual 1

Interventions

Cytarabine 2 venetoclax 1 sugemalimab 1 Tyrosine Kinase Inhibitors 1 Sorafenib 1 Methotrexate 1 Fish Oils 1 Docosahexaenoic Acids 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neoplasm, Residual × sugemalimab × Clear all

NCT05623267 2023-08-07

SURPASS

Sun Yat-sen University

Phase 2/3 Recruiting

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡